Advanced BioMedical Technologies, Inc. Net Change in Cash
Advanced BioMedical Technologies, Inc. reported Net Change in Cash of -$194.68 thousand for the 9-month period ending 2021-07-31, per its 10-Q filed 2021-09-13.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2021-09-13
- Advanced BioMedical Technologies, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2021-01-31 was -$193.17K, a 7845.51% decline year-over-year.
- Advanced BioMedical Technologies, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2020-01-31 was $2.49K, a 75.27% decline year-over-year.
- Advanced BioMedical Technologies, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2019-01-31 was $10.09K, a 10.80% decline year-over-year.
- Advanced BioMedical Technologies, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2018-01-31 was $11.31K.
- Advanced BioMedical Technologies, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2020 was $196.07K.
- Advanced BioMedical Technologies, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2019 was -$1.27K.
- Advanced BioMedical Technologies, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2018 was -$603.00, a 166.70% decline from fiscal 2017.
- Advanced BioMedical Technologies, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2017 was $904.00.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2021-07-31 | -$194.68K 10-Q · filed 2021-09-13 | |||
| 2021-04-30 | -$195.66K 10-Q · filed 2021-06-21 | |||
| 2021-01-31 | -$193.17K 10-Q · filed 2021-03-22 | |||
| 2020-10-31 | $196.07K 10-K · filed 2021-01-29 | |||
| 2020-07-31 | $8.88K 10-Q · filed 2021-09-13 | |||
| 2020-04-30 | $5.05K 10-Q · filed 2021-06-21 | |||
| 2020-01-31 | $2.49K 10-Q · filed 2021-03-22 | |||
| 2019-10-31 | -$1.27K 10-K · filed 2021-01-29 | |||
| 2019-07-31 | $4.02K 10-Q · filed 2020-09-21 | |||
| 2019-04-30 | $5.02K 10-Q · filed 2020-06-22 | |||
| 2019-01-31 | $10.09K 10-Q/A · filed 2020-08-20 | |||
| 2018-10-31 | -$603.00 10-K · filed 2020-03-20 | |||
| 2018-07-31 | $8.49K 10-Q · filed 2019-09-20 | |||
| 2018-04-30 | $6.02K 10-Q · filed 2019-06-19 | |||
| 2018-01-31 | $11.31K 10-Q · filed 2019-04-01 | |||
| 2017-10-31 | $904.00 10-K/A · filed 2019-03-29 |